NEW YORK (GenomeWeb) – Agenovir, a company pursuing antiviral therapies based on engineered nucleases, has announced a $10.6 million Series A financing.

Data Collective led the round, joined by Celgene, Lightspeed Venture Partners, and several individual investors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.